Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection

Ipilimumab, in combination with nivolumab, is one of the promising drugs that enhance the anti-tumor immune response of patients with advanced melanoma. Since the co-administration of nivolumab with ipilimumab in the neoadjuvant setting expands melanoma-reactive T cells at the primary site of melano...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Med (Lausanne)
Egile Nagusiak: Fujimura, Taku, Kambayashi, Yumi, Sato, Yota, Tanita, Kayo, Amagai, Ryo, Hashimoto, Akira, Hidaka, Takanori, Aiba, Setsuya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2019
Gaiak:
Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607934/
https://ncbi.nlm.nih.gov/pubmed/31297373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00140
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak